Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Four countries to boycott Eurovision 2026 over Israel’s inclusion - 2Exploring the Difficulties of Beginning a Family: Individual Experiences
- 3Kennedy approves adding two rare disorders to newborn screenings
- 4The Incomparable Advanced cameras: Which One Will Win?
- 5Overhaul Your Rest: Tips for a Serene Evening
- The 20 Most sultry Style of the Time
- 4K televisions for Extreme Film Watching Experience
- SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025
- Nestlé recalls infant formula in 49 countries. See list.
- An Excursion Through Renowned Western Network programs
- Journalist reported killed in the Gaza Strip
- Southern Californians, your health insurance costs could rise in 2026
- Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- Fossils unearthed in Morocco are first from little-understood period of human evolution
